Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
242.89
+1.05 (0.43%)
At close: Mar 4, 2026, 4:00 PM EST
242.89
0.00 (0.00%)
After-hours: Mar 4, 2026, 5:29 PM EST
Insulet Revenue
In the year 2025, Insulet had annual revenue of $2.71B with 30.73% growth. Insulet had revenue of $783.80M in the quarter ending December 31, 2025, with 31.18% growth.
Revenue (ttm)
$2.71B
Revenue Growth
+30.73%
P/S Ratio
6.35
Revenue / Employee
$501,500
Employees
5,400
Market Cap
17.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.71B | 636.50M | 30.73% |
| Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
| Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
| Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
| Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
| Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
| Dec 31, 2019 | 738.20M | 174.40M | 30.93% |
| Dec 31, 2018 | 563.80M | 100.00M | 21.56% |
| Dec 31, 2017 | 463.80M | 96.81M | 26.38% |
| Dec 31, 2016 | 366.99M | 103.10M | 39.07% |
| Dec 31, 2015 | 263.89M | 32.57M | 14.08% |
| Dec 31, 2014 | 231.32M | -15.76M | -6.38% |
| Dec 31, 2013 | 247.08M | 35.72M | 16.90% |
| Dec 31, 2012 | 211.37M | 59.11M | 38.83% |
| Dec 31, 2011 | 152.26M | 55.29M | 57.02% |
| Dec 31, 2010 | 96.97M | 30.93M | 46.85% |
| Dec 31, 2009 | 66.03M | 29.97M | 83.12% |
| Dec 31, 2008 | 36.06M | 22.69M | 169.66% |
| Dec 31, 2007 | 13.37M | 9.71M | 265.06% |
| Dec 31, 2006 | 3.66M | 3.61M | 7,226.00% |
| Dec 31, 2005 | 50.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.23B |
| Smith & Nephew | 6.16B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Bio-Rad Laboratories | 2.58B |
PODD News
- 5 days ago - Insulet: The Growth Doesn't Stop Here - Seeking Alpha
- 13 days ago - Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations - Seeking Alpha
- 14 days ago - Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars - Benzinga
- 14 days ago - Insulet beats quarterly estimates on strong demand for wearable insulin pumps - Reuters
- 14 days ago - Insulet Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 27 days ago - Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care - Business Wire
- 6 weeks ago - Is PODD A Better Bet Than ISRG Stock? - Forbes